A Selective Serotonin Receptor Agonist for Weight Loss and Management of Menopausal Vasomotor Symptoms in Overweight Midlife Women: a Pilot Study

OBJECTIVE: Weight gain and vasomotor symptoms (VMS) are common complaints in midlife women going through the menopause transition. A selective serotonin 2C (5-HT2C) receptor agonist, loracaserin, that was previously FDA-approved for weight loss, has unreported observational evidence suggesting impro...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Menopause
Main Authors: Kapoor, Ekta, Faubion, Stephanie, Hurt, Ryan T., Fischer, Karen, Schroeder, Darrell, Fokken, Shawn, Croghan, Ivana T.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7676489/
https://ncbi.nlm.nih.gov/pubmed/33110038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001599
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker